Common Covid antibiotic not much effective

eAwaz Medicine

New York – A new study, published in the Journal of the American Medical Association, has found antibiotic azithromycin was no more effective than a placebo in preventing symptoms of Covid-19 among non-hospitalised patients. Azithromycin, a broad-spectrum antibiotic, is widely prescribed as a treatment for COVID-19 in the US and the rest of the world. Lead author Catherine E. Olde burg from the University of California at San Francisco, said: “These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection. The hypothesis is that it has anti-inflammatory properties that may help prevent progression if treated early in the disease.” The study included 263 participants who all tested positive for SARS-CoV-2 within seven days before entering the study. The researchers concluded that treatment with a single dose of azithromycin compared to placebo did not result in a greater likelihood of being symptom-free. Oldenburg concluded: “Most of the trials done so far with azithromycin have focused on hospitalized patients with pretty severe disease.”